Du är här


Kemira Oyj: Kemira Oyj achieves a settlement with CDC in the damage claim litigation in Helsinki, Finland

Kemira Oyj

Stock Exchange Release
May 19, 2014 at 8.30 am (CET+1)

Kemira has signed an agreement with CDC Cartel Damage Claims Hydrogen Peroxide
SA and CDC Holding SA (together "CDC") to settle a lawsuit in Helsinki,
Finland. The settlement concerns claims assigned to CDC based on which CDC
claimed compensation for alleged damages relating to the alleged old
infringement of competition law in the hydrogen peroxide business during
1994-2000. CDC has agreed to withdraw the damage claims and Kemira has agreed
to pay to CDC a compensation of EUR 18.5 million and will compensate CDC for
its legal costs.

Kemira is satisfied with the settlement as it removes the uncertainty related
to the litigation outcome. The settlement also includes significant
limitations of liabilities for Kemira regarding the still pending legal
actions filed by CDC entities in the Regional Court of Dortmund, Germany in
2009 and in the municipal court in Amsterdam, Netherlands in 2011. Kemira
will continue to defend itself against these claims.

For more information, please contact

Kemira Oyj
Jukka Hakkila, Group General Counsel
+358 40 544 2303

Tero Huovinen, VP, Investor Relations
+358 10 862 1980
is a global chemicals company serving customers in water-intensive industries.
We provide expertise and chemicals that improve our customers' water, energy
and raw material efficiency. Our focus is on pulp&paper, oil&gas, mining and
water treatment. In 2013, Kemira had annual revenue of EUR 2.2 billion and
around 4,500 employees. Kemira shares are listed on the NASDAQ OMX Helsinki


Link to the release


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Kemira Oyj via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.